Second primary cancers and survival in patients with gastric cancer: association with prediagnosis lifestyles.


Journal

European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)
ISSN: 1473-5709
Titre abrégé: Eur J Cancer Prev
Pays: England
ID NLM: 9300837

Informations de publication

Date de publication:
05 2019
Historique:
pubmed: 19 4 2018
medline: 2 8 2019
entrez: 19 4 2018
Statut: ppublish

Résumé

To quantify the association between prediagnosis lifestyles with the risk of second primary cancers (SPCs) and survival of patients with gastric first primary cancer (FPC). We recruited 574 gastric patients from two major public hospitals in North Portugal (2001-2006). Smoking, alcohol and dietary habits in the year before FPC diagnosis were evaluated. Patients were followed up to 31 December 2011 for an SPC and to 31 May 2017 for vital status. Cox proportional hazards regression was used to estimate adjusted hazard ratios for incidence of an SPC or death. During follow-up, SPCs were diagnosed in five women and 23 men, and 409 patients died, corresponding to an estimated 10-year cumulative incidence of 5.2% for SPC and an estimated 15-year cumulative mortality of 72.1%. A significantly higher hazard ratio (95% confidence interval) for SPCs was observed in patients reporting a higher consumption of red and processed meat versus the lowest third (4.49: 1.31-15.37), and for mortality in those with heavy alcohol intake versus never drinkers (1.73: 1.00-2.99) and excess weight versus normal weight (1.31: 1.04-1.65); no other significant associations were observed according to prediagnosis lifestyle. Prediagnosis lifestyles may affect the occurrence of an SPC and survival among gastric FPC survivors in the long term.

Identifiants

pubmed: 29668653
doi: 10.1097/CEJ.0000000000000447
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Pagination

159-166

Auteurs

Samantha Morais (S)

EPIUnit, Instituto de Saúde Pública, Universidade do Porto.

Clara Castro (C)

EPIUnit, Instituto de Saúde Pública, Universidade do Porto.
Registo Oncológico Regional do Norte (RORENO), Instituto Português de Oncologia do Porto.

Luís Antunes (L)

Registo Oncológico Regional do Norte (RORENO), Instituto Português de Oncologia do Porto.

Bárbara Peleteiro (B)

EPIUnit, Instituto de Saúde Pública, Universidade do Porto.
Departamento de Ciências da Saúde Pública e Forenses e Educação Médica, Faculdade de Medicina da Universidade do Porto, Porto, Portugal.

Maria J Bento (MJ)

Registo Oncológico Regional do Norte (RORENO), Instituto Português de Oncologia do Porto.

Nuno Lunet (N)

EPIUnit, Instituto de Saúde Pública, Universidade do Porto.
Departamento de Ciências da Saúde Pública e Forenses e Educação Médica, Faculdade de Medicina da Universidade do Porto, Porto, Portugal.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH